CATALYST PHARMACEUTICAL PARTNERS, INC. | 2013 | FY | 3


Accrued expenses and other liabilities consist of the following as of December 31:

 

     2013      2012  

Accrued pre-clinical and clinical trial expenses

   $ 1,083,749       $ 197,572   

Accrued professional fees

     117,240         51,050   

Accrued compensation and benefits

     14,539         5,949   

Accrued license fees

     65,000         15,000   

Deferred rent

     2,746         765   

Other

     5,546         10,666   
  

 

 

    

 

 

 

Current accrued expenses and other liabilities

     1,288,820         281,002   

Deferred rent—non-current

     19,131         21,878   
  

 

 

    

 

 

 

Non-current accrued expenses and other liabilities

     19,131         21,878   
  

 

 

    

 

 

 

Total accrued expenses and other liabilities

   $ 1,307,951       $ 302,880   
  

 

 

    

 

 

 

us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock